Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.54 |
| ▸ | GLP1R | P43220 | 8/20 | 0.50 |
| ▸ | FAAH | O00519 | 4/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.47 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.47 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.47 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.47 |
| ▸ | CASP2 | P42575 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15259286 | 0.98 | CES2 (0.57) | CES2GLP1RFAAHDNM1LPAR1 | |
| SCHEMBL17697369 | 0.98 | CES2 (0.57) | CES2GLP1RFAAHDNM1LPAR1 | |
| SCHEMBL15259277 | 0.96 | CES2 (0.54) | CES2GLP1RFAAHDNM1LPAR1 | |
| SCHEMBL15107494 | 0.96 | CES2 (0.54) | CES2GLP1RFAAHDNM1LPAR1 | |
| SCHEMBL19369946 | 0.96 | CES2 (0.54) | CES2GLP1RFAAHDNM1LPAR1 | |
| SCHEMBL20230390 | 0.96 | CES2 (0.54) | CES2GLP1RFAAHDNM1LPAR1 | |
| SCHEMBL24484088 | 0.95 | CES2 (0.51) | CES2GLP1RFAAHDNM1LPAR1 | |
| SCHEMBL23729610 | 0.89 | CES2 (0.49) | CES2GLP1RFAAHLPAR1LPAR2 | |
| SCHEMBL7650140 | 0.89 | FAAH (0.62) | GLP1RFAAHDNM1LPAR1LPAR2 | |
| SCHEMBL7646590 | 0.89 | FAAH (0.62) | GLP1RFAAHDNM1LPAR1LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4218927-A2 | COMPOSITIONS COMPRISING CHEMERIN ANALOGS AND METHODS OF USE | Okyo Pharma Limited (GG) | 2023-08-02 | — | — | EP | disclosed |